Oxtex, an Oxford, UK- based medical device start up that manufactures anisotropic self-inflating tissue expanders, has completed a £150k funding round.
Backers include a syndicate of LBA angels.
The company intends to use the new capital to develop its technology, gain medical approvals for use in the European Union (MHRA) and the U.S.A (FDA), establish a small clean room manufacturing facility for the production of clinical devices and initiate clinical trials.
A spinout from the University of Oxford, and led by CEO David Jackson, the company is developing a product range based on hydrogel technology which provides novel soft tissue expansion solutions which can address a wide range of clinical applications across reconstructive surgery and dentistry.
FinSMEs
08/03/2012